FDA Accelerates Review for XCath Robotics' Remote Stroke Treatment System

XCath Robotics' Iris System, designed for remote robotic-assisted stroke thrombectomy, has been accepted into the FDA's TAP Pilot program. This follows its Breakthrough Device Designation and aims to expedite the system's development and availability. The technology could significantly expand access to critical stroke care by allowing specialists to perform surgeries remotely, addressing geographic barriers.